Menu
Recruiting NCT06604052

A Study Comparing Laparoscopic/Robotic Stoma Reduced-Port Fusion Surgery with Traditional Surgery in Patients with Temporary Ileostomy

No phase Interventional Ileostomy

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Reduced-Port Fusion Surgery, Traditional surgery.
Who it may be relevant to
Registry conditions: Ileostomy. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Prospective, Randomized, Parallel-Controlled Study Comparing Laparoscopic/Robotic Stoma Reduced-Port Fusion Surgery with Traditional Surgery in Patients with Temporary Ileostomy

Overview

The traditional positioning and surgical methods for temporary ileostomy no longer meet the requirements of minimally invasive surgery: (1) Conventional stoma positioning often leads to the trocar incision being too close to the stoma site, increasing the risk of baseplate leakage and skin infection. (2) Since stoma positioning is required to be within the rectus abdominis, the proximity between the stoma and auxiliary incision can heighten difficulties in stoma bag attachment and raises the risk of fecal leakage. (3) Stoma retraction surgery within the rectus abdominis is more traumatic and complex. We introduce for the first time a modified stoma positioning and surgical method, termed Reduced-Port Fusion Surgery. This technique includes preoperative trocar/stoma fusion positioning and intraoperative trocar/stoma fusion surgery. The procedure is based on the 3R principles: Reposition - the stoma is repositioned within the Joint Trocar/Stoma Zone, allowing for more lateral placement to meet surgical needs without being confined to the rectus abdominis. Reduce Port - the same fusion point is used for both trocar insertion and stoma creation, enabling dual use of one site. Recognize - surgeons participate in stoma positioning, recognize the positioning, and follow the procedure. This prospective, randomized, parallel-controlled clinical study aims to evaluate whether Reduced-Port Fusion Surgery can reduce stoma-related complications, postoperative pain, improve quality of life, and facilitate stoma retraction surgery compared to traditional methods. A total of 80 participants will be randomly assigned in a 1:1 ratio. The experimental group will undergo Reduced-Port Fusion Surgery while the control group will receive traditional surgery.

Interventions

  • Procedure Reduced-Port Fusion Surgery
    (1) The Joint Trocar/Stoma Zone will be delineated by the stoma therapist. (2) The placement of the fusion point will involve collaboration between the surgeon and stoma therapist. This will be based on the surgeon\'s trocar placement plan and the stoma therapist\'s positioning principles. (3) Follow the principles of modified stomal positioning. (4) The surgeon will insert the main trocar based on the preoperative positioning point. During stoma creation, the 12 mm main trocar incision
  • Procedure Traditional surgery
    (1) The stoma therapists perform stoma positioning using traditional stoma positioning method. The surgeon will determine the primary trocar location, ensuring it does not overlap with the stoma site. (2) The surgeon will insert the primary trocar based on the preoperative positioning point and conduct the surgery. During stoma creation, the surgeons create ileal stoma according to the preoperative stoma positioning point.

Primary outcome measures

  • Overall complication rate of stoma [Time frame: 7, 30, and 90 days after surgery]
Secondary outcome measures (6)
  • DET(Discoloration,Erosion and Tissue overgrowth) score [Time frame: 7, 30, and 90 days after surgery]
  • Stomal skin infection rate [Time frame: 7, 30, and 90 days after surgery]
  • Parastostomy trocar incision infection rate [Time frame: 7, 30, and 90 days after surgery]
  • Parastomal hernia rate [Time frame: 7, 30, and 90 days after surgery]
  • Stoma Pain Score [Time frame: 7, 30, and 90 days after surgery]
  • Quality of life scale score [Time frame: 30 and 90 days after surgery]

Eligibility criteria

Inclusion criteria

  • After preoperative evaluation, patients scheduled for laparoscopic/robotic colorectal surgery (rectum, sigmoid colon, left colon) who are planned to undergo prophylactic ileostomy.
  • No serious systemic infection or immunosuppression.
  • Over 18 years of age.
  • Eastern Cooperative Oncology Group Performance Status: 0-1
  • The expected survival time > 6 months.
  • The subjects voluntarily participate and sign the informed consent

Exclusion criteria

  • Any skin infectious diseases in the abdominal wall.
  • Use hormones and immunosuppressive drugs within 1 month before surgery.
  • The time between operation and the last chemotherapy was less than 1 month.
  • Any previous ostomy surgery.
  • Any serious active infection or uncontrollable infection that requires systematic treatment.
  • A clear history of neurological or psychiatric disorders.
  • Subjects may not be able to complete the study for other reasons.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

China · 1 center
  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine — Shanghai

Identifiers

NCT: NCT06604052 · XHEC-C-2024-158-2

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗